| Website | flagshipventures.com |
| Phone | 617 868 1888 |
| Employees |
| Flagship Ventures Fund IV, 1/12 | $270M |
Flagship Ventures is an early-stage venture capital firm focused on creating, financing, and building innovative companies in the Life Science and Technology sectors. Headquartered in Cambridge, MA, Flagship Ventures was founded in 2000 and manages $900 million in capital. Prior to its founding, Flagship’s principals were involved as founders or investors in over 100 firms including: Adolor, AltaVista, Anesta, Antigenics, Aspect Medical, Astral Point, Celera Genomics, ChemGenics Pharmaceuticals, Color Kinetics, Chantry Networks, Cytyc, DataSage, Exact Sciences, IDEXX, PerSeptive Biosystems, Somatogen, Telecorp PCS and TripAdvisor.
The Flagship investment team consists of 10 professionals and is led by co-founders Noubar Afeyan and Ed Kania. Complementing their internal team which has extensive network of academic and industrial advisors who are actively engaged in evaluating and helping develop new ventures.
| Company | Date | Round | Size | Participants |
| Polatis | 2/12 | Unattributed | $2.7M | 5 |
| Blend Therapeutics | 1/12 | Series A | $2.8M | 2 |
| Agios Pharmaceuticals | 11/11 | Series C | $78M | 4 |
| T2 Biosystems | 8/11 | Series D | $23M | 10 |
| ExactCost | 6/11 | Unattributed | $8.5M | 1 |
| Kovio | 6/11 | Unattributed | $15M | 7 |
| Seventh Sense Biosystems | 5/11 | Series A | $4.5M | 3 |
| TARIS Biomedical | 4/11 | Series B | $18.3M | 4 |
| LS9 | 12/10 | Series D | $30M | 5 |
| Accuri Cytometers | 10/10 | Series E | $6M | 5 |
| Visterra | 8/10 | Series A | $6M | 3 |
| Bind Biosciences | 6/10 | Series C | $12.4M | 4 |
| Acceleron Pharma | 6/10 | Unattributed | $8.4M | 5 |
| Everyday Solutions | 6/10 | Unattributed | $2.81M | 3 |
| Tetraphase Pharmaceuticals | 6/10 | Series C | $45M | 6 |
| T2 Biosystems | 5/10 | Series C | $15M | 9 |
| Joule Unlimited | 4/10 | Series B | $30M | 1 |
| Selecta Biosciences | 4/10 | Series C | $15M | 5 |
| TransMedics | 3/10 | Series E | $36M | 11 |
| Eleven Biotherapeutics | 3/10 | Series A | $35M | 2 |
| Receptos | 11/09 | Series A | $25M | 4 |
| LS9 | 10/09 | Series C | $25M | 4 |
| Alvine Pharmaceuticals | 9/09 | Series A | $21.5M | 6 |
| Pervasis Therapeutics | 8/09 | Series C | $17.4M | 3 |
| Accuri Cytometers | 8/09 | Series D | $4M | 5 |
| Advanced Electron Beams | 8/09 | Series C | $14.2M | 6 |
| Novomer | 8/09 | Series B | $14M | 4 |
| Kovio | 7/09 | Series E | $20M | 11 |
| TARIS Biomedical | 6/09 | Series A | $15M | 3 |
| Polatis | 6/09 | Unattributed | $8M | 7 |
| Carbon Design Systems | 5/09 | Series E | $7.5M | 3 |
| Parasol Therapeutics | 5/09 | Series A | $3.25M | 3 |
| Seahorse Bioscience | 3/09 | Series D | $6M | 7 |
| Selecta Biosciences | 2/09 | Series B | $15.1M | 4 |
| Black Duck Software | 2/09 | Series D | $9.5M | 8 |
| Tetraphase Pharmaceuticals | 8/08 | Series A | $15M | 5 |
| Mascoma | 5/08 | Series C | $61M | 4 |
| Concert Pharmaceuticals | 4/08 | Series C | $37M | 12 |
| Pervasis Therapeutics | 1/08 | Unattributed | $9.75M | 4 |
| Carbon Design Systems | 1/08 | Unattributed | $6M | 3 |
| Novomer | 11/07 | Series A | $6.6M | 2 |
| BDNA | 10/07 | Series D | $20M | 4 |
| Interactive Supercomputing | 10/07 | Series B | $11M | 5 |
| LS9 | 10/07 | Series B | $15M | 3 |
| Kovio | 9/07 | Series D | $19.5M | 10 |
| Adnexus | 8/07 | Series C | $15.5M | 5 |
| Tira Wireless | 7/07 | Series D | $5M | 4 |
| TransMedics | 4/07 | Series D | $25.5M | 9 |
| Netuitive | 4/07 | Series D | $8M | 7 |
| LS9 | 3/07 | Series A | $5M | 2 |
| Black Duck Software | 2/07 | Series C | $12M | 6 |
| Codon Devices | 12/06 | Series B | $20M | 5 |
| Concert Pharmaceuticals | 11/06 | Series B | $48.5M | 8 |
| Mascoma | 11/06 | Unattributed | $30M | 7 |
| SiCortex | 10/06 | Series B | $21M | 6 |
| Carbon Design Systems | 9/06 | Series D | $5M | 3 |
| Acceleron Pharma | 8/06 | Series B | $30M | 6 |
| Adnexus | 6/06 | Series B | $27M | 4 |
| Zingku | 6/06 | Unattributed | $1M | 1 |
| Tira Wireless | 3/06 | Series C | $13M | 2 |
| Calpurnia Corporation | 1/06 | Series B | $8M | 4 |
| Interactive Supercomputing | 1/06 | Series A | $4.5M | 3 |
| T2 Biosystems | 1/06 | Unattributed | $5.5M | 3 |
| Carbon Design Systems | 9/05 | Series C | $5.35M | 3 |
| Pervasis Therapeutics | 8/05 | Series B | $17.4M | 3 |
| Extraprise | 8/05 | Unattributed | $5.1M | 8 |
| Ellacoya Networks | 7/05 | Unattributed | $13.5M | 5 |
| Black Duck Software | 6/05 | Series B | $12M | 6 |
| Codon Devices | 5/05 | Series A | $13M | 3 |
| Netuitive | 5/05 | Series C | $5M | 5 |
| Tira Wireless | 3/05 | Series B | $2.5M | 3 |
| Revivio | 1/05 | Series C | $25M | 7 |
| Integrated Development Enterprise | 1/05 | Unattributed | $1.5M | 4 |
| Black Duck Software | 7/04 | Series A | $5M | 3 |
| ZoomInfo | 7/04 | Series A | $7M | 5 |
| Ensemble Discovery | 5/04 | Series A | $15M | 3 |
| TransMedics | 1/04 | Series B | $27.6M | 8 |
